Adial Completes Final Packaging of AD04 for Shipment to Phase 3 Trial Clinical Sites October 29, 2019
Adial Pharmaceuticals Receives Notice of Allowance from US Patent and Trademark Office for Patent for the Treatment of Alcohol Use Disorder in Patients Identified Using a Molecular Genetic Biomarker October 17, 2019
